1. Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps
   Álvaro Marín-Hernández et al, 2016, Front. Physiol. CrossRef
2. Secondary metabolites of Mirabilis jalapa structurally inhibit Lactate Dehydrogenase A in silico: a potential cancer treatment
   R Kusumawati et al, 2018, IOP Conf. Ser.: Mater. Sci. Eng. CrossRef
3. Prevention of autoimmune diabetes and islet allograft rejection by beta cell expression of XIAP: Insight into possible mechanisms of local immunomodulation
   Mercè Obach et al, 2018, Molecular and Cellular Endocrinology CrossRef
4. Melatonin Cytotoxicity Is Associated to Warburg Effect Inhibition in Ewing Sarcoma Cells.
   Carmen Rodriguez, 0 CrossRef
5. Oxamate Improves Glycemic Control and Insulin Sensitivity via Inhibition of Tissue Lactate Production in db/db Mice
   Weiran Ye et al, 2016, PLoS ONE CrossRef
6. Targeting cancer cell mitochondria as a therapeutic approach: recent updates
   Qingbin Cui et al, 2017, Future Medicinal Chemistry CrossRef
7. Ultrasound Promoted Oxamate Synthesis: A Chemoselective and Direct Approach from Amines
   Jyoti Omprakash Rathi et al, 2020, ChemistrySelect CrossRef
8. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A
   Huiling Li et al, 2016, Oncotarget CrossRef
9. Kinetic modeling of glucose central metabolism in hepatocytes and hepatoma cells
   Álvaro Marín-Hernández et al, 2020, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
10. TET2 suppresses nasopharyngeal carcinoma progression by inhibiting glycolysis metabolism.
    Xixia Zhang et al, 2020, Cancer Cell Int CrossRef
11. Rapid and Highly Sensitive Electrochemical Technique for Cell Viability Assay via Monitoring of Intracellular NADH with New Double Mediator System
    Mohammad Abdul ALIM et al, 2021, Electrochemistry CrossRef
12. Oxamate targeting aggressive cancers with special emphasis to brain tumors.
    Meric A Altinoz et al, 2022, Biomed Pharmacother CrossRef
13. Lactate Dehydrogenase Inhibitors Suppress Borrelia burgdorferi Growth In Vitro
    Adam Lynch et al, 2023, Pathogens CrossRef
14. Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
    Jung Ho Han et al, 2023, Front. Pharmacol. CrossRef
15. Targeting the lactic acid metabolic pathway for antitumor therapy
    Zhi Li et al, 2023, Molecular Therapy - Oncolytics CrossRef
16. Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia.
    Andrew J Monteith et al, 2024, Cancer Res CrossRef
17. Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma
    Xiaopei Peng et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
18. Lactate and lactylation in gastrointestinal cancer: Current progress and perspectives (Review)
    Yufen He et al, 2024, Oncol Rep CrossRef
19. EFFECT OF ADHESIVE LLC CELL PRETREATMENT BY OXAMATE ON THE SURVIVAL INDEXES AFTER TRANSITION TO DE-ADHESIVE GROWTH
    Yu. STEPANOV et al, 2024, Exp. oncol. CrossRef
20. Histone lactylation-mediated overexpression of RASD2 promotes endometriosis progression via upregulating the SUMOylation of CTPS1
    Ziwei Wang et al, 2025, American Journal of Physiology-Cell Physiology CrossRef